Angiogenic inhibitor pre‐administration improves the therapeutic effects of immunotherapy

In lung cancer, immune checkpoint inhibitors (ICIs) are often inadequate for tumor growth inhibition. Angiogenic inhibitors (AIs) are required to normalize tumor vasculature for improved immune cell infiltration. However, in clinical practice, ICIs and cytotoxic antineoplastic agents are simultaneou...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Mineyoshi, Maishi, Nako, Hida, Yasuhiro, Yanagawa‐Matsuda, Aya, Alam, Mohammad Towfik, Sakakibara‐Konishi, Jun, Nam, Jin‐Min, Onodera, Yasuhito, Konno, Satoshi, Hida, Kyoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166916/
https://www.ncbi.nlm.nih.gov/pubmed/36808261
http://dx.doi.org/10.1002/cam4.5696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166916/
https://www.ncbi.nlm.nih.gov/pubmed/36808261
http://dx.doi.org/10.1002/cam4.5696

Ejemplares similares